Current evidence suggests its safety profile is manageable and consistent with the incretin class, with no major safety barriers identified to date
Cautionary Voices from Experts While the idea of GLP1 agonism induction of depression and SI is controversial with both negative and positive reporting, based on the evidence presented in this article by Alireza Sharafshah, a PhD candidate from Cellular and Molecular Research Center, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran, the authors caution against promoting chronic stimulation via GLP-1 agonists
Singh AK, Singh R (2020) Gender difference in cardiovascular outcomes with SGLT-2 inhibitors and GLP-1 receptor agonist in type 2 diabetes: a systematic review and meta-analysis of cardio-vascular outcome trials
San Joses active lifestyle culture provides excellent resources for sustaining results through hiking trails in nearby mountains, cycling routes throughout the valley, and recreational sports leagues that make fitness enjoyable year-round
doi: 10.2215/CJN.08580718 130 SalibaA.DebnathS.TamayoI.TumovaJ.MaddoxM.SinghP.et al